GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jinyu Bio-Technology Co Ltd (SHSE:600201) » Definitions » Change In Receivables

Jinyu Bio-Technology Co (SHSE:600201) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jinyu Bio-Technology Co Change In Receivables?

Jinyu Bio-Technology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Jinyu Bio-Technology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Jinyu Bio-Technology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-67 Mil. It means Jinyu Bio-Technology Co's Accounts Receivable increased by ¥67 Mil from Dec. 2022 to Dec. 2023 .

Jinyu Bio-Technology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥755 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Jinyu Bio-Technology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 198.15.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Jinyu Bio-Technology Co's liquidation value for the three months ended in Mar. 2024 was ¥1,292 Mil.


Jinyu Bio-Technology Co Change In Receivables Historical Data

The historical data trend for Jinyu Bio-Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinyu Bio-Technology Co Change In Receivables Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.53 -61.89 -125.10 -70.17 -67.03

Jinyu Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Jinyu Bio-Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinyu Bio-Technology Co  (SHSE:600201) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Jinyu Bio-Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=755.472/347.901*91
=198.15

2. In Ben Graham's calculation of liquidation value, Jinyu Bio-Technology Co's accounts receivable are only considered to be worth 75% of book value:

Jinyu Bio-Technology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1720.036-1144.701+0.75 * 755.472+0.5 * 301.037
=1,292

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinyu Bio-Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Jinyu Bio-Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinyu Bio-Technology Co (SHSE:600201) Business Description

Traded in Other Exchanges
N/A
Address
No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
Executives
Zhang Chong Yu Director
Zhang Jing Directors, senior managers
Yang Zhao senior management
Li Rong senior management
Zhang Zhan Fu Supervisors
Wei Xue Feng Director
Wang Yong Sheng Directors, senior managers
Yin Song Tao Directors, senior managers
Liu Guo Ying Supervisors
Zhang Hong Mei senior management
Wen Li Min Director
Xu Xian Ming Director
Xu Shi Jun Director
Wang Xiu Hua Director
Li Shu Jian senior management

Jinyu Bio-Technology Co (SHSE:600201) Headlines

No Headlines